The Cureiosity® Database

The Cureiosity® database plays an important role in identifying new drug *repurposing opportunities.

The Cureiosity® database maps connections between drugs, diseases and therapeutic targets in dimensions heretofore unseen; it will be continuously populated with the latest scientific research by data-mining experts employed by the Center’s “Knowledge Unit.” The Cureiosity® database will serve as the key informational resource for current and future personalized and precision medicine clinics.

The Center for Drug Repurposing is the world’s first academic drug repurposing center. It utilize academic expertise and resources to speed the R&D process of drug repurposing for the benefit of patients worldwide. The center enables patients to benefit from real-life target-driven drug repurposing opportunities.

Drug rediscovery is an innovative approach for drug development. Many approved medicinal products have multiple additional uses beyond those for which they have been approved. Discovering and developing new indications and innovative pharmaceutical forms and routes of administration usually results in better, faster treatments at a greatly reduced financial risk.

The ever-rising bar of regulatory requirements, the steeply rising costs of clinical trials and the lack of candidates for new drug development has led to the rapid growth of the repurposed drug market. As of 2012, the number of repurposed drug candidates (505(b)(2)) approvals in the USA has exceeded that of new drugs and the exponential growth rate continues. Drug rediscovery delivers pharmacological- therapeutic progress and addresses unmet medical needs.

The Center for Drug Repurposing (CDR) is a unique Public Private Partnership – operated jointly by Ariel University and Drug Rediscovery Ltd.

* Drug repurposing is the application of known drugs and compounds to new diseases.

A significant advantage of drug repurposing over traditional drug development is that since the repurposed drug has already passed a significant number of toxicity and other tests, its safety is already known reducing the cost, time, development of much needed medications.